MedTech Europe One Of 15 Orgs Telling Brexit Negotiators To Include Specific Health Measures
Executive Summary
Health organizations are up in arms over the lack of consideration of health and patients in the latest EU Brexit texts. They have written to the European Commission and may release an public statement.
You may also be interested in...
Precarious Draft Brexit Agreement: How It Could Impact The Medtech Sector
The UK does not know which direction its future will take, with respect to its current leadership and its relationship with the EU, from one hour to the next. But if the EU/UK Brexit Draft Agreement is accepted, there will be some short-term relief for the medtech sector.
Why The European Pharmaceutical Strategy Matters So Much For The Devices Sector
The regulation of medicines and medical devices have long worked along parallel, but very different, lines. Now there is increasing pressure for them to also be jointly improved to support innovation.
Time To Comment On ‘Bold New Regulatory Regime’ For UK
Unconstrained by having to compromise with other countries’ regulatory approaches, the UK is now seeking views on its proposal for a pioneering and “bold new regulatory regime” for medtech products.